{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:40:49Z","timestamp":1780605649853,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.radcr.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:03:35Z","timestamp":1751357015000},"page":"4774-4777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arteritic anterior ischemic optic neuropathy secondary to immune checkpoint inhibitors: A case report"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-1193","authenticated-orcid":false,"given":"Zahin","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tausif Ahmed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-1694","authenticated-orcid":false,"given":"Mohammed Usman","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6186-3676","authenticated-orcid":false,"given":"Pavan K.","family":"Kottamasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akm","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.radcr.2025.06.014_bib0001","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.4103\/aian.aian_533_22","article-title":"Ischemic optic neuropathies","volume":"25","author":"Patil","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"10.1016\/j.radcr.2025.06.014_bib0002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J Neuroophthalmol"},{"issue":"11","key":"10.1016\/j.radcr.2025.06.014_bib0003","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.radcr.2025.06.014_bib0004","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0161-6420(87)33263-4","article-title":"Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis","volume":"94","author":"Beck","year":"1987","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.radcr.2025.06.014_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bjophthalmol-2021-319537","article-title":"MRI signs helpful in the differentiation of patients with anterior ischaemic optic neuropathy and optic neuritis","volume":"107","author":"Petroulia","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.radcr.2025.06.014_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.radcr.2025.06.014_bib0008","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/s41433-024-03212-z","article-title":"Impact of immune checkpoint inhibitors on vision and eye health","volume":"38","author":"Masalkhi","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.radcr.2025.06.014_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2022.1044904","article-title":"Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: current status and future directions","volume":"2","author":"Winges","year":"2022","journal-title":"Front Ophthalmol"},{"issue":"17","key":"10.1016\/j.radcr.2025.06.014_bib0010","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with Immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.radcr.2025.06.014_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CJI.0000000000000394","article-title":"Eosinophilic vasculitis and arteritic anterior ischemic optic neuropathy associated with Anti-PD-L1 therapy","volume":"45","author":"Berry","year":"2022","journal-title":"J Immunother"},{"issue":"10","key":"10.1016\/j.radcr.2025.06.014_bib0012","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.3390\/ijms25105490","article-title":"Immunomodulatory precision: a narrative review exploring the critical role of immune checkpoint inhibitors in cancer treatment","volume":"25","author":"Qiu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"10304","key":"10.1016\/j.radcr.2025.06.014_bib0013","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.radcr.2025.06.014_bib0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncr.31043","article-title":"Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non\u2013small cell lung cancer: a systematic analysis of the literature","volume":"124","author":"Pillai","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.radcr.2025.06.014_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1167975","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a review","volume":"14","author":"Yin","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.radcr.2025.06.014_bib0016","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","article-title":"Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review","volume":"28","author":"Khoja","year":"2017","journal-title":"Ann Oncol"},{"issue":"36","key":"10.1016\/j.radcr.2025.06.014_bib0017","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radcr.2025.06.014_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coi.2021.02.002","article-title":"Adverse events induced by immune checkpoint inhibitors","volume":"69","author":"Perdigoto","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"16","key":"10.1016\/j.radcr.2025.06.014_bib0019","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.3390\/ijms21165774","article-title":"Immune-driven pathogenesis of neurotoxicity after exposure of cancer patients to immune checkpoint inhibitors","volume":"21","author":"Vilari\u00f1o","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193004332500559X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193004332500559X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:29:26Z","timestamp":1765456166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193004332500559X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S193004332500559X"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2025.06.014","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arteritic anterior ischemic optic neuropathy secondary to immune checkpoint inhibitors: A case report","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}